“Missing Mutation” Found in Severe Infant Epilepsy
Published on
CHOP has found a long-suspected “missing mutation” in severe infant epilepsy, with early hints that anti-seizure drugs might help patients.
Published on
CHOP has found a long-suspected “missing mutation” in severe infant epilepsy, with early hints that anti-seizure drugs might help patients.
Published on
In a rare genetic disorder causing severe, progressive neurological problems, CHOP researchers find hints that an amino acid supplement might be a targeted therapy.
Published on
The Leukodystrophy Center sees patients from all over the country and the world. Our services include a newborn diagnostic clinic and a comprehensive care clinic that provides state-of-the art care.
Published on
The Pediatric MS and Neuroimmune Clinic at CHOP provides treatment to children with neuroimmune conditions through coordinated care across many specialties.
Published on
Since its inception, the Neuroscience Biorepository has collected more than 2,500 samples from more than 80 individuals, and plans to launch pilot grants with the samples.
Published on
Meet Drs. Baker and Beslow, who joined the Wolfson Laboratory to expand both clinical and instrument development parts of the lab.
Published on
The Pediatric Epilepsy Program is one of the largest and most interdisciplinary programs of its kind in the world, with expertise covering all aspects of epilepsy management.
Published on
Al Jalila Children’s has entered into a Memorandum of Understanding with Children's Hospital of Philadelphia to collaborate on a dedicated neurology outreach program.
Published on
An event hosted by CHOP’s Pediatric Stroke Program focuses on cognitive and behavioral recovery after childhood stroke, an area with significant research potential.
Published on
On April 22, 2017, about 25 patients and their family members came out for a fun-filled day at the annual Keto Party.